{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:48:37Z","timestamp":1788400117197,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.carrev.2025.08.004","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T02:39:17Z","timestamp":1754620757000},"page":"136-144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Heparin pretreatment in patients with ST-segment elevation myocardial infarction: A meta-analysis"],"prefix":"10.1016","volume":"82","author":[{"given":"Luca","family":"Franchin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Angriman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Pezzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca Siega","family":"Vignut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Fabris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianfranco","family":"Sinagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnoud W.J.","family":"van 't Hof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Imazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2025.08.004_bb0010","unstructured":"Abciximab in patients with acute ST-segment\u2013elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading | Circulation [Internet]. [cited 2024 Jul 20]. Available from: https:\/\/www.ahajournals.org\/doi\/10.1161\/circulationaha.108.818617"},{"issue":"9957","key":"10.1016\/j.carrev.2025.08.004_bb0015","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(14)60924-7","article-title":"Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial","volume":"384","author":"Shahzad","year":"2014","journal-title":"The Lancet"},{"issue":"9638","key":"10.1016\/j.carrev.2025.08.004_bb0020","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(08)61235-0","article-title":"Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (on-TIME 2): a multicentre, double-blind, randomised controlled trial","volume":"372","author":"Van\u2019t Hof","year":"2008","journal-title":"Lancet Lond Engl"},{"issue":"10","key":"10.1016\/j.carrev.2025.08.004_bb0025","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0002-9149(01)02040-9","article-title":"Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current era (the Mayo Clinic experience)","volume":"88","author":"Singh","year":"2001","journal-title":"Am J Cardiol"},{"issue":"9","key":"10.1016\/j.carrev.2025.08.004_bb0030","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.amjcard.2005.06.056","article-title":"Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes","volume":"96","author":"Rao","year":"2005","journal-title":"Am J Cardiol"},{"issue":"7","key":"10.1016\/j.carrev.2025.08.004_bb0035","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1161\/hq0701.093686","article-title":"Mechanism of action and pharmacology of unfractionated heparin","volume":"21","author":"Hirsh","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.carrev.2025.08.004_bb0040","author":"Emilsson"},{"key":"10.1016\/j.carrev.2025.08.004_bb0045","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"issue":"15","key":"10.1016\/j.carrev.2025.08.004_bb0050","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.carrev.2025.08.004_bb0055","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"issue":"7414","key":"10.1016\/j.carrev.2025.08.004_bb0060","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.carrev.2025.08.004_bb0065","author":"Wells"},{"issue":"6","key":"10.1016\/j.carrev.2025.08.004_bb0070","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00019501-199809060-00003","article-title":"Confirmation that heparin is an alternative means of promoting early reperfusion","volume":"9","author":"Braga","year":"1998","journal-title":"Coron Artery Dis"},{"issue":"11","key":"10.1016\/j.carrev.2025.08.004_bb0075","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/S0735-1097(02)01856-9","article-title":"Influence of prehospital administration of aspirin and heparin on initial patency of the infarct-related artery in patients with acute st elevation myocardial infarction","volume":"39","author":"Zijlstra","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.carrev.2025.08.004_bb0080","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1253\/circj.71.862","article-title":"Effects of the early administration of heparin in patients with ST-elevation myocardial infarction treated by primary angioplasty","volume":"71","author":"Chung","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.carrev.2025.08.004_bb0085","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijcard.2015.06.009","article-title":"Time-dependent effects of unfractionated heparin in patients with ST-elevation myocardial infarction transferred for primary angioplasty","volume":"198","author":"Giralt","year":"2015","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.carrev.2025.08.004_bb0090","first-page":"15","article-title":"Editor\u2019s choice- heparin pre-treatment in patients with ST-segment elevation myocardial infarction and the risk of intracoronary thrombus and total vessel occlusion. Insights from the TASTE trial","volume":"8","author":"Karlsson","year":"2019","journal-title":"European Heart Journal: Acute Cardiovascular Care"},{"issue":"3","key":"10.1016\/j.carrev.2025.08.004_bb0095","first-page":"519","article-title":"Upstream anticoagulation for patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the TOTAL trial","volume":"96","author":"Cantor","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.carrev.2025.08.004_bb0100","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/FJC.0000000000000865","article-title":"Prehospital administration of unfractionated heparin in ST-segment elevation myocardial infarction is associated with improved long-term survival","volume":"76","author":"McGinley","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"issue":"10","key":"10.1016\/j.carrev.2025.08.004_bb0105","first-page":"1140","article-title":"Pre-hospital heparin use for ST-elevation myocardial infarction is safe and improves angiographic outcomes","volume":"10","author":"Bloom","year":"2021","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.carrev.2025.08.004_bb0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijcard.2020.09.058","article-title":"Impact of pre-angioplasty antithrombotic therapy administration on coronary reperfusion in ST-segment elevation myocardial infarction: does time matter?","volume":"325","author":"Giralt","year":"2021","journal-title":"Int J Cardiol"},{"issue":"9","key":"10.1016\/j.carrev.2025.08.004_bb0115","first-page":"709","article-title":"Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish coronary angiography and angioplasty registry (SCAAR)","volume":"18","author":"Emilsson","year":"2022","journal-title":"EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol"},{"issue":"5","key":"10.1016\/j.carrev.2025.08.004_bb0120","first-page":"1500","article-title":"Effect of prehospital treatment in STEMI patients undergoing primary PCI","volume":"99","author":"Fabris","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"10.1016\/j.carrev.2025.08.004_bb0125","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.3390\/jcm13061710","article-title":"Parenteral anticoagulation at first medical contact improves infarct related artery patency in STEMI","volume":"13","author":"Bataila","year":"2024","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.carrev.2025.08.004_bb0130","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0735-1097(99)00597-5","article-title":"High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial","volume":"35","author":"Liem","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.carrev.2025.08.004_bb0135","author":"Chen"},{"issue":"2","key":"10.1016\/j.carrev.2025.08.004_bb0140","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0735-1097(97)00495-6","article-title":"High dose bolus heparin as initial therapy before primary angioplasty for acute myocardial infarction: results of the Heparin in Early Patency (HEAP) pilot study","volume":"31","author":"Verheugt","year":"1998","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.carrev.2025.08.004_bb0145","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jama.1996.03540100055028","article-title":"Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. JAMA","volume":"276","author":"Oler","year":"1996","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.carrev.2025.08.004_bb0150","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1056\/NEJMoa1407024","article-title":"Prehospital ticagrelor in ST-segment elevation myocardial infarction","volume":"371","author":"Montalescot","year":"2014","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.carrev.2025.08.004_bb0155","first-page":"519","article-title":"Upstream anticoagulation for patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the TOTAL trial","volume":"96","author":"Cantor","year":"2020","journal-title":"Catheter Cardiovasc Interv"},{"issue":"9","key":"10.1016\/j.carrev.2025.08.004_bb0160","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4244\/EIJ-D-22-00432","article-title":"Pretreatment with heparin in patients with ST-segment elevation myocardial infarction: a report from the Swedish Coronary Angiography and Angioplasty Registry (SCAAR)","volume":"18","author":"Emilsson","year":"2022","journal-title":"EuroIntervention"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925004087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838925004087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:24:21Z","timestamp":1770855861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838925004087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":31,"alternative-id":["S1553838925004087"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2025.08.004","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heparin pretreatment in patients with ST-segment elevation myocardial infarction: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2025.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}